CRISTINA DORTA: Open Payments
NPI 1750790150 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,387 in 247 payments from 36 companies in 2025. Trend: 2023 $0 · 2024 $3,430 · 2025 $5,387
Food & beverage: $5,346Education: $40
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 20 | $584 |
| Neurocrine BioSciences, Inc. | 18 | $462 |
| PFIZER INC. | 19 | $362 |
| ARGENX US, INC. | 14 | $315 |
| ABBVIE INC. | 14 | $300 |
| CSL Behring | 9 | $241 |
| Amgen Inc. | 6 | $230 |
| ACADIA Pharmaceuticals Inc | 11 | $229 |
| Amneal Pharmaceuticals LLC | 11 | $226 |
| Eisai Inc. | 12 | $219 |
Products named: INGREZZA, NURTEC ODT, Rystiggo, Leqembi, Hizentra, NUPLAZID, CREXONT, AUSTEDO XR.
Industry payments across FL — which companies pay providers there.
